NUMARK has welcomed the Public Health England (PHE) report, Evidence review of e-cigarettes and heated tobacco products 2018, which was commissioned to summarise evidence to underpin policy and regulation of e-cigarettes and vaping devices.
The report outlines key findings, including that in the first half of 2017 quit rates were at their highest rates observed so far, and for the first time, there was parity across different socio-economic groups and it was plausible that e-cigarettes had contributed to this.
E-cigarettes used, alone or in combination with licensed medication and behavioural support from a Stop Smoking Service, appeared to be helpful in the short-term, although fewer smokers used an e-cigarette as part of a quit attempt with a Stop Smoking Service compared with licensed medication.
The report recommends that stop smoking practitioners and health professionals should “provide behavioural support to smokers who want to use an e-cigarette to help them quit smoking.”
Laure Reed, head of professional development at Numark said: “Numark is delighted that PHE have recognised the important role health professionals play in supporting patients to quit traditional and more harmful cigarettes. After a number of years of controversy, we champion the need to get e-cigarettes licensed in the UK and also support the prospect for them to be prescribed under UK prescribing laws.
“Whilst there is little imperial evidence of the long-term safety of the e-cigarettes, PHE say that they are 95% less harmful than smoking and could contribute significantly to public health in the long-term.
“It is important that patients recognise the vital role pharmacy plays in improving their health and providing the advice and resources needed to enable them to choose the most appropriate solutions to help them make key lifestyle changes.
“The findings from this report are a positive step forwards to promoting the use of licensed e-cigarettes as a smoking cessation aid and anything that can be done to increase the opportunities to facilitate interaction with pharmacy and their communities should be applauded.”